Which medications might be considered for stabilizing a newborn?

The choice of glucose, antibiotics, or surfactant therapy is particularly important for stabilizing a newborn, especially in the context of common neonatal complications. Glucose is essential in managing hypoglycemia, which can occur in newborns, especially those who are premature or have other risk factors. Administering glucose helps to ensure that the infant has adequate energy availability, which is critical for proper metabolic function.

Antibiotics are routinely considered for newborns who may show signs of infection, as they are at significant risk for sepsis. Prompt administration of appropriate antibiotics can help protect these vulnerable patients from serious infections that could jeopardize their stability and overall health.

Surfactant therapy is specifically indicated for premature infants suffering from respiratory distress syndrome (RDS), a condition linked to a deficiency of surfactant in the lungs. Administering surfactant helps reduce surface tension in the alveoli, improving lung expansion and function, which is vital for oxygenation and stabilization of the infant.

In contrast, while the other choices may contain medications relevant in different contexts, they do not align as closely with the immediate needs for stabilization in newborns.